Dl-Penicillamine

Dl-Penicillamine

SCHEMBL7932150

CC(C)(S)[C@H](N)C(=O)O.N

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.95
PTGS1 P23219 2/20 0.95
MAPT P10636 2/20 0.95
SLC7A5 Q01650 2/20 0.36
SLC7A11 Q9UPY5 1/20 0.35
GRIK1 P39086 1/20 0.32
ENPEP Q07075 3/20 0.32
SLC1A3 P43003 1/20 0.31
SLC1A2 P43004 1/20 0.31
SLC1A1 P43005 1/20 0.31
HPGD P15428 2/20 0.30
HSD17B10 Q99714 2/20 0.30
TDP1 Q9NUW8 2/20 0.30
ABCB11 O95342 1/20 0.30
F2 P00734 1/20 0.30
TP53 P04637 1/20 0.30
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
ALOX15 P16050 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Penicillamine SCHEMBL7932147 1.00 ALDH1A1 (0.95) ALDH1A1PTGS1MAPTSLC7A5SLC7A11
Penicillamine SCHEMBL4343 0.97
Dl-Penicillamine SCHEMBL57527 0.97
Dl-Penicillamine SCHEMBL22322162 0.97 ALDH1A1 (1.00) ALDH1A1PTGS1MAPTSLC7A5SLC7A11
Penicillamine SCHEMBL603349 0.97 ALDH1A1 (1.00) ALDH1A1PTGS1MAPTSLC7A5SLC7A11
Penicillamine SCHEMBL129296 0.97 ALDH1A1 (1.00) ALDH1A1PTGS1MAPTSLC7A5SLC7A11
Dl-Penicillamine SCHEMBL4344 0.97
Dl-Penicillamine SCHEMBL159653 0.97 ALDH1A1 (1.00) ALDH1A1PTGS1MAPTSLC7A5SLC7A11
Penicillamine SCHEMBL6654084 0.95
Penicillamine SCHEMBL10789333 0.95 ALDH1A1 (0.95) ALDH1A1PTGS1MAPTSLC7A5SLC7A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140178-A2 USE OF A MATRIX METALLAPROTEINASE INHIBITOR AND RADIATION AS A COMBINED TREATMENT OF NEOPLASIA G.D. SEARLE & CO. (US) 2001-10-10 EP disclosed
WO-2000038717-A2 USE OF A MATRIX METALLOPROTEINASE INHIBITOR AND RADIATION AS A COMBINED TREATMENT OF NEOPLASIA G.D. SEARLE & CO. (US) 2000-07-06 WO disclosed